Rising Mental Health Awareness Will Boost ZURZUVAE Adoption
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 12 Analysts
Published
08 Aug 25
Updated
08 Aug 25
AnalystHighTarget's Fair Value
US$11.27
23.0% undervalued intrinsic discount08 Aug
US$8.68
1Y
-9.6%7D
-1.4%